Dr Rajan Kapoor, MBBS | |
2149 E Warner Rd Ste 101, Tempe, AZ 85284-3495 | |
(804) 610-6100 | |
(480) 464-0189 |
Full Name | Dr Rajan Kapoor |
---|---|
Gender | Male |
Speciality | Nephrology |
Experience | 18 Years |
Location | 2149 E Warner Rd Ste 101, Tempe, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376881177 | NPI | - | NPPES |
069299 | Other | GA | GA LICENSES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | 069299 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ahwatukee Dialysis (fmc) | Phoenix, AZ | Dialysis facility |
Chandler Regional Medical Center | Chandler, AZ | Hospital |
Banner - University Medical Center Phoenix | Phoenix, AZ | Hospital |
Mercy Gilbert Medical Center | Gilbert, AZ | Hospital |
Banner Baywood Medical Center | Mesa, AZ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Banner - University Super Specialists Llc | 1850695255 | 22 |
Southwest Kidney Institute Plc | 8224930987 | 81 |
News Archive
New findings from The Parkinson Alliance (PA) survey entitled "Autonomic Dysfunction in Parkinson's Disease With and Without Deep Brain Stimulation" show that autonomic dysfunction was highly prevalent in Parkinson's disease (PD), regardless of age and disease duration.
Neurocrine Biosciences, Inc. today announced top-line efficacy and safety results from a Phase II clinical trial utilizing Corticotropin Releasing Factor (CRF1) receptor antagonist GSK561679 in patients currently experiencing a major depressive episode.
The use of an oral anticoagulant medicine in medically ill patients for 45 days following their discharge from the hospital reduces the rate of non-fatal symptomatic blood clots with no impact on fatal blood clots, according to late breaking results from the MARINER trial presented today in a Hot Line Session at ESC Congress 2018 and published in The New England Journal of Medicine.
Analysis of a drug regimen approved by the F.D.A. in 2006 for the treatment of non-small cell lung cancer (bevacizumab added to the standard chemotherapy regimen carboplatin and paclitaxel) finds Medicare insured patients age 65 years and older who received this regimen did not have improved survival compared to patients who received the standard treatment of carboplatin and paclitaxel alone, according to a study in the April 18 issue of JAMA.
› Verified 7 days ago
Entity Name | Southwest Kidney Institute Plc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659316008 PECOS PAC ID: 8224930987 Enrollment ID: O20040211001069 |
News Archive
New findings from The Parkinson Alliance (PA) survey entitled "Autonomic Dysfunction in Parkinson's Disease With and Without Deep Brain Stimulation" show that autonomic dysfunction was highly prevalent in Parkinson's disease (PD), regardless of age and disease duration.
Neurocrine Biosciences, Inc. today announced top-line efficacy and safety results from a Phase II clinical trial utilizing Corticotropin Releasing Factor (CRF1) receptor antagonist GSK561679 in patients currently experiencing a major depressive episode.
The use of an oral anticoagulant medicine in medically ill patients for 45 days following their discharge from the hospital reduces the rate of non-fatal symptomatic blood clots with no impact on fatal blood clots, according to late breaking results from the MARINER trial presented today in a Hot Line Session at ESC Congress 2018 and published in The New England Journal of Medicine.
Analysis of a drug regimen approved by the F.D.A. in 2006 for the treatment of non-small cell lung cancer (bevacizumab added to the standard chemotherapy regimen carboplatin and paclitaxel) finds Medicare insured patients age 65 years and older who received this regimen did not have improved survival compared to patients who received the standard treatment of carboplatin and paclitaxel alone, according to a study in the April 18 issue of JAMA.
› Verified 7 days ago
Entity Name | Banner - University Super Specialists Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740650555 PECOS PAC ID: 1850695255 Enrollment ID: O20160204002443 |
News Archive
New findings from The Parkinson Alliance (PA) survey entitled "Autonomic Dysfunction in Parkinson's Disease With and Without Deep Brain Stimulation" show that autonomic dysfunction was highly prevalent in Parkinson's disease (PD), regardless of age and disease duration.
Neurocrine Biosciences, Inc. today announced top-line efficacy and safety results from a Phase II clinical trial utilizing Corticotropin Releasing Factor (CRF1) receptor antagonist GSK561679 in patients currently experiencing a major depressive episode.
The use of an oral anticoagulant medicine in medically ill patients for 45 days following their discharge from the hospital reduces the rate of non-fatal symptomatic blood clots with no impact on fatal blood clots, according to late breaking results from the MARINER trial presented today in a Hot Line Session at ESC Congress 2018 and published in The New England Journal of Medicine.
Analysis of a drug regimen approved by the F.D.A. in 2006 for the treatment of non-small cell lung cancer (bevacizumab added to the standard chemotherapy regimen carboplatin and paclitaxel) finds Medicare insured patients age 65 years and older who received this regimen did not have improved survival compared to patients who received the standard treatment of carboplatin and paclitaxel alone, according to a study in the April 18 issue of JAMA.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Rajan Kapoor, MBBS 2149 E Warner Rd Ste 101, Tempe, AZ 85284-3495 Ph: (804) 610-6100 | Dr Rajan Kapoor, MBBS 2149 E Warner Rd Ste 101, Tempe, AZ 85284-3495 Ph: (804) 610-6100 |
News Archive
New findings from The Parkinson Alliance (PA) survey entitled "Autonomic Dysfunction in Parkinson's Disease With and Without Deep Brain Stimulation" show that autonomic dysfunction was highly prevalent in Parkinson's disease (PD), regardless of age and disease duration.
Neurocrine Biosciences, Inc. today announced top-line efficacy and safety results from a Phase II clinical trial utilizing Corticotropin Releasing Factor (CRF1) receptor antagonist GSK561679 in patients currently experiencing a major depressive episode.
The use of an oral anticoagulant medicine in medically ill patients for 45 days following their discharge from the hospital reduces the rate of non-fatal symptomatic blood clots with no impact on fatal blood clots, according to late breaking results from the MARINER trial presented today in a Hot Line Session at ESC Congress 2018 and published in The New England Journal of Medicine.
Analysis of a drug regimen approved by the F.D.A. in 2006 for the treatment of non-small cell lung cancer (bevacizumab added to the standard chemotherapy regimen carboplatin and paclitaxel) finds Medicare insured patients age 65 years and older who received this regimen did not have improved survival compared to patients who received the standard treatment of carboplatin and paclitaxel alone, according to a study in the April 18 issue of JAMA.
› Verified 7 days ago
Dr. Steven Alex Baldwin, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1898 E Southern Ave, Tempe, AZ 85282 Phone: 480-838-0068 Fax: 480-838-3409 | |
Denise I Beighe, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 451 E University Dr, Tempe, AZ 85281 Phone: 480-965-3346 Fax: 480-965-8914 | |
Dr. M. Jamil Akhtar, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2157 E Baseline Rd, Suite 101, Tempe, AZ 85283 Phone: 480-962-9494 Fax: 480-962-8140 | |
Emil Slovak Jr., M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4600 S Mill Ave, Suite 280, Tempe, AZ 85282 Phone: 480-305-2888 Fax: 480-305-2889 | |
Supriya Bhandari, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1840 E Broadway Rd, Tempe, AZ 85282 Phone: 602-243-7277 Fax: 480-927-1092 | |
Dr. Monaliza Setudehnia, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2055 E Southern Ave, Suite D, Tempe, AZ 85282 Phone: 480-345-7676 | |
Dr. Vanessa Joyce Tang, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1920 E Baseline Rd, Tempe, AZ 85283 Phone: 480-453-5000 Fax: 480-345-5266 |